Literature DB >> 12923015

Cardiovascular risk factors in patients with aortic stenosis predict prevalence of coronary artery disease but not of aortic stenosis: an angiographic pair matched case-control study.

J R Ortlepp1, F Schmitz, T Bozoglu, P Hanrath, R Hoffmann.   

Abstract

BACKGROUND: Traditional cardiovascular risk factors have been associated with aortic stenosis and coronary artery disease. As these two conditions often co-exist, the association of cardiovascular risk factors with aortic stenosis may reflect confounding.
OBJECTIVE: To compare the cardiovascular risk profile in patients with severe aortic stenosis undergoing elective coronary angiography with that of patients without aortic stenosis or calcification undergoing coronary angiography for suspected coronary artery disease.
METHODS: 523 patients referred for elective diagnostic left heart catheterisation because of severe aortic stenosis formed the case population; 3925 patients without valve disease referred for elective diagnostic left heart catheterisation formed the base control population. Of the latter, 523 were pair matched to the case population for sex, age, and prevalence of relevant coronary artery disease, forming a pair matched control population. Cardiovascular risk factors (male sex, hypertension, hypercholesterolaemia, smoking, diabetes mellitus, family history of coronary artery disease) were assessed in all the patients.
RESULTS: None of the cardiovascular risk factors was more prevalent in patients with aortic stenosis than in the base control population or in the pair matched control population. However, male sex, hypercholesterolaemia, smoking, diabetes mellitus, and a family history of coronary artery disease were significantly associated with the presence of additional coronary artery disease in patients with aortic stenosis.
CONCLUSIONS: Cardiovascular risk factors are commonly present in patients with aortic stenosis. However, when compared with controls matched for age, sex, and angiographically defined coronary artery disease, no risk factor was significantly associated with the prevalence of aortic stenosis. Thus other factors are likely to be more important in the pathogenesis of aortic stenosis.

Entities:  

Mesh:

Year:  2003        PMID: 12923015      PMCID: PMC1767856          DOI: 10.1136/heart.89.9.1019

Source DB:  PubMed          Journal:  Heart        ISSN: 1355-6037            Impact factor:   5.994


  15 in total

1.  The vitamin D receptor genotype predisposes to the development of calcific aortic valve stenosis.

Authors:  J R Ortlepp; R Hoffmann; F Ohme; J Lauscher; F Bleckmann; P Hanrath
Journal:  Heart       Date:  2001-06       Impact factor: 5.994

2.  Factors of risk in the development of coronary heart disease--six year follow-up experience. The Framingham Study.

Authors:  W B KANNEL; T R DAWBER; A KAGAN; N REVOTSKIE; J STOKES
Journal:  Ann Intern Med       Date:  1961-07       Impact factor: 25.391

Review 3.  An update on coronary risk factors.

Authors:  W B Kannel; P W Wilson
Journal:  Med Clin North Am       Date:  1995-09       Impact factor: 5.456

Review 4.  Aortic stenosis.

Authors:  J Ross; E Braunwald
Journal:  Circulation       Date:  1968-07       Impact factor: 29.690

5.  Correlation of serum lipids, calcium, and phosphorus, diabetes mellitus and history of systemic hypertension with presence or absence of calcified or thickened aortic cusps or root in elderly patients.

Authors:  W S Aronow; K S Schwartz; M Koenigsberg
Journal:  Am J Cardiol       Date:  1987-04-15       Impact factor: 2.778

6.  Effect of hydroxymethylglutaryl coenzyme a reductase inhibitors on the progression of calcific aortic stenosis.

Authors:  G M Novaro; I Y Tiong; G L Pearce; M S Lauer; D L Sprecher; B P Griffin
Journal:  Circulation       Date:  2001-10-30       Impact factor: 29.690

Review 7.  Familial calcification of aorta and calcific aortic valve disease associated with immunologic abnormalities.

Authors:  C Tentolouris; T Kontozoglou; P Toutouzas
Journal:  Am Heart J       Date:  1993-10       Impact factor: 4.749

8.  Progression of aortic valve calcification: association with coronary atherosclerosis and cardiovascular risk factors.

Authors:  K Pohle; R Mäffert; D Ropers; W Moshage; N Stilianakis; W G Daniel; S Achenbach
Journal:  Circulation       Date:  2001-10-16       Impact factor: 29.690

9.  Apolipoproteins B, (a), and E accumulate in the morphologically early lesion of 'degenerative' valvular aortic stenosis.

Authors:  K D O'Brien; D D Reichenbach; S M Marcovina; J Kuusisto; C E Alpers; C M Otto
Journal:  Arterioscler Thromb Vasc Biol       Date:  1996-04       Impact factor: 8.311

10.  Prevalence of aortic valve abnormalities in the elderly: an echocardiographic study of a random population sample.

Authors:  M Lindroos; M Kupari; J Heikkilä; R Tilvis
Journal:  J Am Coll Cardiol       Date:  1993-04       Impact factor: 24.094

View more
  16 in total

1.  Stress positron emission tomography is safe and can guide coronary revascularization in high-risk patients being considered for transcatheter aortic valve replacement.

Authors:  Paul C Cremer; Shaden Khalaf; Junyang Lou; Leonardo Rodriguez; Manuel D Cerqueira; Wael A Jaber
Journal:  J Nucl Cardiol       Date:  2014-06-19       Impact factor: 5.952

Review 2.  Potential drug targets for calcific aortic valve disease.

Authors:  Joshua D Hutcheson; Elena Aikawa; W David Merryman
Journal:  Nat Rev Cardiol       Date:  2014-01-21       Impact factor: 32.419

3.  Feasibility and Validity of Computed Tomography-Derived Fractional Flow Reserve in Patients With Severe Aortic Stenosis: The CAST-FFR Study.

Authors:  Michael Michail; Abdul-Rahman Ihdayhid; Andrea Comella; Udit Thakur; James D Cameron; Liam M McCormick; Robert P Gooley; Stephen J Nicholls; Anthony Mathur; Alun D Hughes; Brian S Ko; Adam J Brown
Journal:  Circ Cardiovasc Interv       Date:  2020-12-16       Impact factor: 6.546

4.  APOE alleles are not associated with calcific aortic stenosis.

Authors:  J R Ortlepp; M Pillich; V Mevissen; C Krantz; M Kimmel; R Autschbach; G Langebartels; J Erdmann; R Hoffmann; K Zerres
Journal:  Heart       Date:  2006-04-10       Impact factor: 5.994

5.  An assessment of the safety, hemodynamic response, and diagnostic accuracy of commonly used vasodilator stressors in patients with severe aortic stenosis.

Authors:  Nasir Hussain; Waseem Chaudhry; Alan W Ahlberg; Richard S Amara; Ahmed Elfar; Matthew W Parker; John A Savino; Ruwanthi Titano; Milena J Henzlova; William L Duvall
Journal:  J Nucl Cardiol       Date:  2016-03-15       Impact factor: 5.952

6.  Aortic valve area: meta-analysis of diagnostic performance of multi-detector computed tomography for aortic valve area measurements as compared to transthoracic echocardiography.

Authors:  Rajnil G Shah; Gian M Novaro; Rodolfo J Blandon; Mitchell S Whiteman; Craig R Asher; Jacobo Kirsch
Journal:  Int J Cardiovasc Imaging       Date:  2009-05-07       Impact factor: 2.357

7.  Risk stratification and management of aortic stenosis with concomitant left ventricular dysfunction.

Authors:  Matthew L Steinhauser; Peter H Stone
Journal:  Curr Treat Options Cardiovasc Med       Date:  2007-12

8.  Risk factors for degenerative aortic valve disease in India: A case control study.

Authors:  D S Chadha; S K Malani; P Bharadwaj; G Karthikeyan; P K Hasija
Journal:  Med J Armed Forces India       Date:  2017-04-18

9.  Predictors of coronary and carotid atherosclerosis in patients with severe degenerative aortic stenosis.

Authors:  Beata Bobrowska; Wojciech Zasada; Andrzej Surdacki; Tomasz Rakowski; Paweł Kleczyński; Jolanta Świerszcz; Olga Kruszelnicka; Renata Rajtar-Salwa; Saleh Arif; Danuta Sorysz; Dariusz Dudek; Jacek S Dubiel
Journal:  Int J Med Sci       Date:  2013-08-19       Impact factor: 3.738

10.  The percutaneous coronary intervention prior to transcatheter aortic valve implantation (ACTIVATION) trial: study protocol for a randomized controlled trial.

Authors:  Muhammed Zeeshan Khawaja; Duolao Wang; Stuart Pocock; Simon Robert Redwood; Martyn Rhys Thomas
Journal:  Trials       Date:  2014-07-24       Impact factor: 2.279

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.